Factors associated with initiation and persistence of urate-lowering therapy

類似資料

• Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
  著者:: Drivelegka, Panagiota, 等
  出版事項: (2018)
• Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
  著者:: Drivelegka, Panagiota, 等
  出版事項: (2018)
• Impact of psoriasis disease activity and other risk factors on serum urate levels in patients with psoriasis and psoriatic arthritis—a post-hoc analysis of pooled data from three phase 3 trials with secukinumab
  著者:: Dehlin, Mats, 等
  出版事項: (2021)
• Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot
  著者:: Drivelegka, Panagiota, 等
  出版事項: (2020)
• Urate-lowering therapy for heart failure
  著者:: O. V. Zhelyabina, 等
  出版事項: (2019-09-01)